Tushara Vijaykumar

Loss of metabolic fitness drives tumor resistance after CAR-NK cell therapy and can be overcome by cytokine engineering

Li Li, Vakul Mohanty, Jinzhuang Dou et al. · Science Advances · 2023 · 94 citations · Full text

Immunology, Nk Cells, Car-nk Cell Therapy +18

Single-cell RNA-seq reveals developmental plasticity with coexisting oncogenic states and immune evasion programs in ETP-ALL

Praveen Anand, Amy Guillaumet-Adkins, Valeriya Dimitrova et al. · Blood · 2020 · 88 citations · Full text

Genomic discovery and clonal tracking in multiple myeloma by cell-free DNA sequencing

Guangwu Guo, Noopur Raje, Charles Seifer et al. · Leukemia · 2018 · 58 citations

Hematological Malignancy, Oncology, Clonal Tracking +12

Dynamic transcriptional reprogramming leads to immunotherapeutic vulnerabilities in myeloma

Julia Frede, Praveen Anand, Noori Sotudeh et al. · Nature Cell Biology · 2021 · 51 citations · Full text

Hematological Malignancy, Immunotherapeutic Vulnerabilities, Immunology +4

A phase II trial of all-trans retinoic acid (ATRA) in advanced adenoid cystic carcinoma

Glenn J. Hanna, Anne O’Neill, Jennifer M. Cutler et al. · Oral Oncology · 2021 · 48 citations

Tumor Biology, Phase Ii Trial, Oncogenic Agent +8